| http://www.w3.org/ns/prov#value | - The College, AACC, and the others are particularly concerned about the role proposed for the FDA. The joint letter said: Under the directive, laboratories developing and conducting in-house genetic tests would essentially be considered ???manufacturers??? and subject to direct FDA oversight???thus forcing them to meet specified regulatory requirements beyond the existing CLIA standards.
|
